.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Queensland Health
Fish and Richardson
Cantor Fitzgerald
Accenture
Johnson and Johnson
Chubb
Argus Health
Farmers Insurance

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088235

« Back to Dashboard
NDA 088235 describes ISONIAZID, which is a drug marketed by Watson Labs, Ivax Sub Teva Pharms, Thepharmanetwork Llc, Hikma Intl Pharms, Mikart, Duramed Pharms Barr, Whiteworth Town Plsn, Panray, Halsey, Purepac Pharm, Sun Pharm Inds, Cmp Pharma Inc, Barr, Mk Labs, Sandoz Inc, Nexgen Pharma Inc, Impax Labs, Perrigo, Phoenix Labs Ny, Sandoz, Pharmavite, and Lilly, and is included in thirty-four NDAs. It is available from twenty-seven suppliers. Additional details are available on the ISONIAZID profile page.

The generic ingredient in ISONIAZID is isoniazid. There are five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the isoniazid profile page.

Summary for NDA: 088235

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 088235

Suppliers and Packaging for NDA: 088235

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ISONIAZID
isoniazid
SYRUP;ORAL 088235 ANDA Carolina Medical Products Company 46287-009 46287-009-01 473 mL in 1 BOTTLE (46287-009-01)
ISONIAZID
isoniazid
SYRUP;ORAL 088235 ANDA Department of State Health Services, Pharmacy Branch 55695-031 55695-031-00 473 mL in 1 BOTTLE (55695-031-00)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength50MG/5ML
Approval Date:Nov 10, 1983TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Accenture
Boehringer Ingelheim
Daiichi Sankyo
McKesson
Argus Health
Fuji
AstraZeneca
Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot